1293914-39-2

Upstream product

• 1188522-31-7 2-O-methyl-3,4:5,6-di-O-isopropylidene-D-glucitol 
• 1293914-28-9 C₁₉H₂₈O₇ 
• 1293914-29-0 C₂₂H₃₄O₇ 
• 1293914-31-4 C₂₂H₃₂O₇ 
• 1293914-33-6 C₂₆H₃₈O₈ 
• 1293914-35-8 C₂₆H₄₀O₇ 
• 1293914-37-0 C₂₆H₄₀O₆ 
• 1293914-30-3 C₂₂H₃₄O₇ 
• 1293914-32-5 C₂₂H₃₂O₇ 
• 1293914-34-7 C₂₆H₃₈O₈ 
• 1293914-36-9 C₂₆H₄₀O₇ 
• 1293914-38-1 C₂₆H₄₀O₆ 
• 1293914-26-7 C₂₀H₃₀O₆ 
• 1293914-27-8 C₁₇H₂₆O₆ 

Downstream Products

• 1293914-41-6 C₂₃H₃₄O₆ 

Relevant academic research and scientific papers

Synthesis of (3S,4R)-bengamide e

(3S,4R)-Bengamide E (2) was synthesized starting from d-glucono-δ- lactone (3) and the key deoxygenation step from 13 to 15 was achieved by the application of NaBH3CN and ZnI2. Compared with natural bengamide E (1), the synthetic compound (3S,4R)-bengamide E (2) was inactive against the cell growth of HUVEC and cancer cells. These data represent the significance of the stereochemistry at C-3 and C-4 of bengamides for structural recognition and binding with the target(s).